Employees receive drugs and money will be responsible for leadership

(Reporter Wu Peng) by the Ministry of Health and other seven ministries issued by the "Medical institutions drug centralized procurement work norms", "drug centralized procurement supervision and management measures", has been formally promulgated and implemented.　　It stipulates that medical institutions personnel receiving drug production and management enterprises money or other interests, not only to hold the parties responsible, depending on the circumstances of the Director of the responsibility of the leadership. The new regulations are clear, if the medical institutions do not participate in drug centralized procurement activities, the provision of false drug procurement history information, not in accordance with the provisions of drug enterprises with the signing of drug purchase and sale contracts, unauthorized procurement of non-shortlisted drugs substitute for shortlisted drugs; or even the temporary retail price of a centralized purchase drug　　, accepting the eight acts, such as money or other interests, of the drug production and Operation company, will be held accountable. The new rules require that, in addition to the accountability of the parties, depending on the circumstances of the leader's responsibility.　　Those suspected of committing a crime shall be transferred to the judicial organs for treatment. What is the evaluation of the drugs that have been purchased centrally? New regulation requirements, evaluation, to increase the weight of drug quality decentralization, comprehensive evaluation, the actual weight of quality elements should not be less than 50% of total, the actual weight of price elements should not be lower than the total score of 30%.